Sun Pharma Labs. Ltd.’s Software Upgradation Expenses classified as Revenue Expenditure: ITAT upholds CIT(A) Ruling

The Ahmedabad Bench of the Income Tax Appellate Tribunal (ITAT) upheld the Commissioner of Income Tax (Appeals) [CIT (A)] ruling that Sun Pharma Laboratories Ltd.'s software upgradation expenses should be classified as revenue expenditures. This classification, totaling ₹1,49,62,413, allows the company to claim immediate deductions under the Income Tax Act, 1961. The expenses, related to data migration, online support, and routine maintenance, were deemed operational rather than capital in nature. The revenue-appellant contested the CIT (A) order dated February 28, 2019, concerning the assessment year 2015-16 under Section 143(3) of the Income Tax Act. The ITAT’s decision supports the view that such software-related costs are integral to the company’s regular business operations and should be treated as revenue expenditures, thus providing tax relief to the company by allowing these costs to be deducted in the year they were incurred.